K Pharma,Inc. (4896.T)
JPY 747.0
(-1.58%)
JPY 747.0
(-1.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 910 Million JPY | 0.0% |
| 2022 | - JPY | 100.0% |
| 2021 | -6.8 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | - JPY | 0.0% |
| 2024 Q1 | - JPY | 0.0% |
| 2023 Q3 | - JPY | 0.0% |
| 2023 Q4 | - JPY | 0.0% |
| 2023 FY | 910 Million JPY | 0.0% |
| 2022 FY | - JPY | 100.0% |
| 2021 FY | -6.8 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 51.629% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1033.166% |
| GNI Group Ltd. | 22.43 Billion JPY | 95.943% |
| Linical Co., Ltd. | 3.77 Billion JPY | 75.915% |
| Trans Genic Inc. | 2.24 Billion JPY | 59.542% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -826.19% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 63.342% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 29.6% |
| AnGes, Inc. | -3.06 Billion JPY | 129.687% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 612.047% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 90.584% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -75.916% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -720.145% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 37.267% |
| CanBas Co., Ltd. | -984 Million JPY | 192.48% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -132.322% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 45.053% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -128.302% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 12.448% |
| PeptiDream Inc. | 17.21 Billion JPY | 94.715% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -2873.37% |
| Ribomic Inc. | -10.5 Million JPY | 8765.016% |
| SanBio Company Limited | -14.5 Million JPY | 6374.131% |
| Healios K.K. | 108 Million JPY | -742.593% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 266962.17% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 1641.171% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 60285.185% |
| StemRIM | -44.34 Million JPY | 2151.906% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 71.429% |
| FunPep Company Limited | -680.28 Million JPY | 233.767% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -1214.079% |
| Stella Pharma Corporation | 217.29 Million JPY | -318.78% |
| TMS Co., Ltd. | -6.95 Million JPY | 13193.525% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -189.292% |
| Cuorips Inc. | 9.63 Million JPY | -9348.655% |
| Takara Bio Inc. | 25.45 Billion JPY | 96.425% |
| ReproCELL Incorporated | 1.1 Billion JPY | 17.626% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 23.853% |
| StemCell Institute Inc. | 1.57 Billion JPY | 42.255% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 45.404% |
| CellSeed Inc. | 107.15 Million JPY | -749.237% |